GMP細胞バンキングサービス市場：細胞タイプ、品質グレード、サービスタイプ、用途、エンドユーザー別-2025-2030年世界予測

GMP細胞バンキングサービス市場は、2024年には9億6,341万米ドルとなり、2025年には10億7,382万米ドル、CAGR 11.97%で成長し、2030年には18億9,868万米ドルに達すると予測されています。

バイオテクノロジーの進化に伴い、GMP細胞バンキング・サービスは、多様な用途向けに高品質な細胞を安定供給するための要として浮上してきました。本レポートでは市場の分析的概要を提供し、医薬品製造管理及び品質管理基準（GMP）の観点から細胞バンキングの複雑さを探り、規制上の要求と科学的進歩の両方を満たすためにサービスがどのように変化してきたかを詳述します。先端治療や新規バイオ医薬品に対する需要の高まりに対応するために市場が拡大するにつれ、強固な細胞バンキングを維持する必要性が不可欠となっています。現在の環境では、細胞処理と保管の正確さだけでなく、運用、物流、技術的課題に対する包括的な理解も求められています。最近の動向、技術革新、規制の変化を総合的に分析することで、この分析は、進化する業界のニーズを満たすために細胞バンキング戦略がどのように適応してきたかについて、貴重な洞察を提供します。考察は、サービスモデル、品質への配慮、運営準備の重要な検証を含み、それにより利害関係者が業界のこれまでを理解し、これから向かう方向を構想するための強固な土台を築くものです。このイントロダクションでは、市場の変遷、戦略的セグメンテーションの洞察、この重要なセクターの成長とイノベーションを促進する主要な地域および企業の力学を詳細に調査するための舞台を整えます。

GMP細胞バンキングサービス市場の変革

GMP細胞バンキング・サービス市場は、過去10年間で大きな変貌を遂げてきました。急速な技術進歩と進化する規制の枠組みが、業界標準と資源配分を再定義しました。この進化の特徴は、最先端の自動化の統合、品質管理プロトコルの強化、最新の治療要件に合わせたプロセスの拡張への戦略的集中です。このような変化の背景には、技術革新はコンプライアンスと手を携えて行われなければならないという認識があり、業界参加者は、効率性と厳格な規制遵守の両方をサポートする強固なインフラに多額の投資を行うよう促されています。

歴史的な観点から見ると、セル・バンキングのプロセスは大部分が手作業で、反応的なものでした。この変化は、業務形態だけでなく、企業がサービス提供の戦略を立てる方法にも影響を及ぼしています。その結果、現在では多くの組織がプロセス最適化ツールや予測分析を活用して、ばらつきを最小限に抑え、生産性を高めています。規制機関もまた、このシフトにおいて極めて重要な役割を果たしており、製造慣行の再調整を余儀なくされる最新のガイドラインを発行しています。この新たな枠組みは、トレーサビリティ、弾力性、拡張性を重視し、将来の成長と革新に向けた市場の位置づけとなっています。利害関係者は現在、リスクを管理し、プロセスを動的に適応させるためのより良い体制を整え、GMP慣行が現行の規制と将来の業界動向の両方に沿ったものであることを保証しています。

GMP細胞バンクサービスの主要セグメント分析

GMP細胞バンキングサービス市場をより深く分析するには、多層的なセグメンテーション構造を検討する必要があります。細胞の種類に基づくセグメンテーションでは、動物細胞とヒト細胞を対比しており、市場調査はそれぞれのカテゴリーに固有の取り扱い、処理、規制要件を考慮しなければならないことを示しています。並行して、品質グレードのセグメンテーションでは、臨床グレードと調査グレードを区別しています。この2つの異なるセグメントは、どちらも極めて重要であるが、コンプライアンス、精度、運営上の監視のレベルが異なります。生産終了セルバンキング、マスターセルバンキング、ワーキングセルバンキングにまたがるサービスタイプのセグメンテーションの多様な性質は、重層的な複雑性と、生産物の品質と運営効率の両方を最大化するために業界各社が利用する独自のアプローチを反映しています。

さらに、用途に基づくセグメンテーションは、市場をさらに階層化する特定の最終用途に関する洞察を提供します。例えば、バイオ医薬品の生産は、モノクローナル抗体と組換えタンパク質の生産に分けられます。この微妙な区分により、これらの製品が現代の治療において果たす重要な役割が浮き彫りになります。研究開発アプリケーションは、細胞治療、遺伝子治療、幹細胞研究を含む画期的な治療法を掘り下げており、各領域では細胞バンクプロトコルの厳格な拡張と適応が要求されます。同様に、組織工学への応用は、バイオプリンティング技術、臓器移植ソリューション、足場をベースとした応用など、技術的飛躍的進歩の中で急速に普及しつつある新興分野を強調するものです。

エンドユーザーに基づくセグメンテーションの最終層（契約研究機関、病院、製薬会社、研究機関など）は、誰がこれらのサービスの恩恵を受けているかを包括的に示します。サービスの種類、品質、用途、エンドユーザーによるセグメンテーションの相互作用は、市場特有の複雑性を示すだけでなく、細胞バンキングの分野でさらなる革新と戦略的進歩を促進すると思われる新たな動向にも光を当てています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加により、効果的かつ効率的な細胞バンクの必要性が高まっている
    • パーソナライズ医療の需要が高まるにつれて、GMP細胞バンキングサービスの必要性が高まります。
    • 世界中でバイオ医薬品および製薬分野への投資が増加
  • 抑制要因
    • GMP細胞バンキングサービスに影響を与えるコストの影響と投資の障害
  • 機会
    • GMP細胞バンキングの精度と信頼性に対する期待を高める技術の進歩
    • 高度な細胞バンクリポジトリを必要とする再生医療と免疫療法の開発
  • 課題
    • GMP準拠と細胞バンキング承認に関する厳格な規制要件
• 市場セグメンテーション分析
  • 細胞タイプ：個別化医療と再生医療の拡大によりヒト細胞の需要が増加
  • エンドユーザー：製薬およびバイオ医薬品分野への投資を増やし、細胞バンキングインフラを強化する,
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 GMP細胞バンキングサービス市場細胞の種類別

• 動物細胞
• ヒト細胞

第7章 GMP細胞バンキングサービス市場品質等級別

• 臨床グレード
• 調査グレード

第8章 GMP細胞バンキングサービス市場：サービスタイプ別

• 生産終了細胞バンキング
• マスターセルバンキング
• ワーキングセルバンキング

第9章 GMP細胞バンキングサービス市場：用途別

• バイオ医薬品製造
  • モノクローナル抗体
  • 組み換えタンパク質
• 研究開発
  • 細胞療法
  • 遺伝子治療
  • 幹細胞調査
• 組織工学
  • バイオプリンティング技術
  • 臓器移植ソリューション
  • スキャフォールドベースのアプリケーション

第10章 GMP細胞バンキングサービス市場：エンドユーザー別

• 契約調査機関
• 病院
• 製薬会社
• 調査機関

第11章 南北アメリカのGMP細胞バンキングサービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のGMP細胞バンキングサービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのGMP細胞バンキングサービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 53Biologics
• Austrianova
• Cell Culture Company, LLC
• Charles River Laboratories
• Clean Cells
• Eurofins Scientific Limited
• ExcellGene SA
• Goodwin Biotechnology Inc.
• Kaneka Eurogentec S.A.
• Lonza Group Ltd.
• Merck KGaA
• NAOBIOS
• PackGene Biotech lnc.
• ProBio Biotech Corporation
• RoslinCT
• SGS Group
• SK pharmteco Inc.
• Takara Bio Inc.
• Texcell SA
• uBriGene Biosciences International Co.
• ViruSure GmbH
• Wacker Chemie AG
• WuXi Biologics

LIST OF FIGURES

• FIGURE 1. GMP CELL BANKING SERVICES MARKET MULTI-CURRENCY
• FIGURE 2. GMP CELL BANKING SERVICES MARKET MULTI-LANGUAGE
• FIGURE 3. GMP CELL BANKING SERVICES MARKET RESEARCH PROCESS
• FIGURE 4. GMP CELL BANKING SERVICES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. GMP CELL BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. GMP CELL BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. GMP CELL BANKING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GMP CELL BANKING SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-OF-PRODUCTION CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MASTER CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY WORKING CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPRINTING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ORGAN TRANSPLANT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SCAFFOLD-BASED APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 64. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 68. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 69. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 105. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 106. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 109. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 110. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 111. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 113. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 114. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 117. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 118. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 119. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 125. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 129. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 130. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 133. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 137. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 138. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 141. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 145. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 146. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 147. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 149. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 153. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 154. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 157. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 169. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 170. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 171. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 173. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 177. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 178. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 181. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 185. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 186. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 187. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 189. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 201. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 202. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 203. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 206. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 210. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 211. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 214. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 218. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 219. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 220. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 222. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 226. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 227. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 230. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 234. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 235. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 238. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 242. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 243. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 244. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 246. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 250. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 251. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 252. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 254. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 255. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 256. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 258. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 259. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 260. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 262. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 266. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 267. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 268. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 270. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 274. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 275. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 278. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 282. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 283. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 284. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 286. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 287. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 288. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 289. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 290. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 291. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 292. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 294. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 295. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 296. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 298. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 299. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 300. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 301. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 302. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 305. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 306. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 307. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 308. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 310. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 313. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 314. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
• TABLE 315. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 316. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 317. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 318. SOUTH AFRICA G

The GMP Cell Banking Services Market was valued at USD 963.41 million in 2024 and is projected to grow to USD 1,073.82 million in 2025, with a CAGR of 11.97%, reaching USD 1,898.68 million by 2030.

In the evolving landscape of biotechnology, GMP Cell Banking Services have emerged as a cornerstone for ensuring the consistent supply of high-quality cells for diverse applications. This report provides an analytical overview of the market, exploring the intricacies of cell banking from the perspective of Good Manufacturing Practice (GMP) and detailing how services have transformed to meet both regulatory demands and scientific advancements. As the market expands to accommodate the rising demand for advanced therapies and novel biopharmaceutical products, the need to maintain robust cell banking practices has become indispensable. The current environment demands not only precision in cell processing and storage but also a comprehensive understanding of the operational, logistical, and technical challenges involved. By synthesizing recent trends, technological innovations, and regulatory shifts, this analysis offers valuable insights into how cell banking strategies have adapted to meet evolving industry needs. The discussion encompasses a critical examination of service models, quality considerations, and operational readiness, thereby laying a solid foundation for stakeholders to appreciate where the industry has been and envision where it is headed. This introductory section sets the stage for a detailed exploration of the market's transformative shifts, strategic segmentation insights, and key regional as well as corporate dynamics that are driving growth and innovation in this vital sector.

Transformative Shifts in GMP Cell Banking Landscape

The GMP Cell Banking Services market has witnessed significant transformative shifts over the past decade. Rapid technological advancements and evolving regulatory frameworks have redefined industry standards and resource allocation. This evolution is characterized by the integration of state-of-the-art automation, enhanced quality control protocols, and a strategic focus on scaling processes to align with modern therapeutic requirements. Underpinning these changes is the recognition that innovation must go hand in hand with compliance, prompting industry participants to invest heavily in robust infrastructure that supports both efficiency and stringent regulatory adherence.

From a historical perspective, cell banking processes were largely manual and reactive, but today they have become a proactive, technology-driven discipline. The shift has influenced not only operational modalities but also how companies strategize their service offerings. As a result, many organizations are now leveraging process optimization tools and predictive analytics to minimize variability and enhance productivity. Regulatory bodies have also played a pivotal role in this shift, issuing updated guidelines that have forced a recalibration of manufacturing practices. This new framework emphasizes traceability, resilience, and scalability, positioning the market for future growth and innovation. Stakeholders are now better equipped to manage risk and adapt their processes dynamically, ensuring that their GMP practices remain aligned with both current regulations and future industry trends.

Key Segmentation Insights for GMP Cell Banking Services

A deeper analysis of the GMP Cell Banking Services market necessitates an examination of its multi-layer segmentation structure. The segmentation based on cell type contrasts between animal cells and human cells, indicating that market studies must account for the unique handling, processing, and regulatory requirements inherent in each category. In parallel, quality grade segmentation differentiates between clinical grade and research grade - two distinct segments that, while both crucial, require varied levels of compliance, precision, and operational oversight. The diverse nature of the service type segmentation, spanning end-of-production cell banking, master cell banking, and working cell banking, reflects the layered complexity and the tailored approaches industry players utilize to maximize both output quality and operational efficiency.

In addition, the segmentation based on application offers insight into specific end uses that further stratify the market. Biopharmaceutical production, for instance, is dissected into the production of monoclonal antibodies and recombinant proteins. This nuanced division highlights the critical role these products play in modern therapeutics. Research and development applications delve into breakthrough therapies including cell therapy, gene therapy, and stem cell research; each domain demands rigorous expansion and adaptation of cell banking protocols. Similarly, tissue engineering applications underscore emerging fields such as bioprinting technologies, organ transplant solutions, and scaffold-based applications - domains that are rapidly gaining traction amid technological breakthroughs.

A final layer of segmentation based on the end-user - which covers contract research organizations, hospitals, pharmaceutical companies, and research institutes - provides a comprehensive view of who is benefiting from these services. The interplay between service type, quality, application, and end-user segmentation not only illustrates the market's inherent complexity but also sheds light on emerging trends that are likely to drive further innovations and strategic advancements in the cell banking arena.

Based on Cell Type, market is studied across Animal Cells and Human Cells.

Based on Quality Grade, market is studied across Clinical Grade and Research Grade.

Based on Service Type, market is studied across End-of-Production Cell Banking, Master Cell Banking, and Working Cell Banking.

Based on Application, market is studied across Biopharmaceutical Production, Research & Development, and Tissue Engineering. The Biopharmaceutical Production is further studied across Monoclonal Antibodies and Recombinant Proteins. The Research & Development is further studied across Cell Therapy, Gene Therapy, and Stem Cell Research. The Tissue Engineering is further studied across Bioprinting Technologies, Organ Transplant Solutions, and Scaffold-Based Applications.

Based on End-User, market is studied across Contract Research Organizations, Hospitals, Pharmaceutical Companies, and Research Institutes.

Exploring Regional Dynamics in GMP Cell Banking Services

Regional characteristics significantly shape the competitive strategies and market performance in GMP Cell Banking Services. The market landscape in the Americas is defined by high investments in technology innovations and a strong regulatory environment, which collectively promote robust infrastructure development. In contrast, the combined markets of Europe, the Middle East, and Africa exhibit a complex interplay between longstanding regulatory frameworks and rapidly evolving technological standards. These regions are characterized by a mix of mature biopharmaceutical ecosystems and emerging economies, which together pave the way for diverse growth trajectories and strategic collaborations.

Asia-Pacific stands out for its dynamic growth fueled by increasing investments in biotechnology and research-oriented cellular therapies. The region's efforts in aligning with global GMP standards while encouraging local innovations have laid the groundwork for impressive scalability and high-capacity production. Each of these regions contributes distinctive insights: while the Americas lead in technological integration, Europe, the Middle East, and Africa bring innovative regulatory solutions to the fore, and Asia-Pacific champions scalability and emerging market solutions. Understanding these regional dynamics is crucial for stakeholders aiming to tailor their strategies to capture localized opportunities while maintaining a competitive edge in the global marketplace.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Driving Market Innovations

The market is populated by numerous leading companies that play a critical role in driving innovation and maintaining high standards in GMP Cell Banking Services. Industry players such as 53Biologics and Austrianova have fostered a culture of excellence through technological innovations that enhance process reliability and quality control. Companies like Cell Culture Company, LLC and Charles River Laboratories continue to set benchmarks in operational efficiency and regulatory compliance, while Clean Cells and Eurofins Scientific Limited bring valuable expertise in ensuring product integrity and safety throughout the cell banking lifecycle.

Notable companies including ExcellGene SA, Goodwin Biotechnology Inc., and Kaneka Eurogentec S.A. are examples of organizations that champion rigorous quality management systems. Further insights into market performance emerge from the contributions of industry leaders like Lonza Group Ltd., Merck KGaA, and NAOBIOS, who invest heavily in R&D and technological modernization. The presence of innovative players such as PackGene Biotech Inc., ProBio Biotech Corporation, and RoslinCT underscores the market's commitment to continuous improvement, while firms like SGS Group, SK pharmteco Inc., Takara Bio Inc., and Texcell SA collectively contribute to an ecosystem characterized by robust compliance and operational innovation.

Moreover, strategic insights have been reinforced by the collaborative efforts of uBriGene Biosciences International Co., ViruSure GmbH, Wacker Chemie AG, and WuXi Biologics. Each of these companies has significantly influenced market trends by integrating cutting-edge technology with advanced therapeutic practices and by setting industry standards that push the boundaries of what is possible in cell banking. Their collective contributions have laid the foundation for a dynamic market environment that is continually evolving to meet the demands of modern healthcare and scientific research.

The report delves into recent significant developments in the GMP Cell Banking Services Market, highlighting leading vendors and their innovative profiles. These include 53Biologics, Austrianova, Cell Culture Company, LLC, Charles River Laboratories, Clean Cells, Eurofins Scientific Limited, ExcellGene SA, Goodwin Biotechnology Inc., Kaneka Eurogentec S.A., Lonza Group Ltd., Merck KGaA, NAOBIOS, PackGene Biotech lnc., ProBio Biotech Corporation, RoslinCT, SGS Group, SK pharmteco Inc., Takara Bio Inc., Texcell SA, uBriGene Biosciences International Co., ViruSure GmbH, Wacker Chemie AG, and WuXi Biologics. Actionable Recommendations for Industry Leaders

Industry leaders must adopt a forward-thinking approach to thrive in an increasingly competitive GMP Cell Banking Services market. It is essential to invest in process automation and digitalization, which can streamline operations and enhance traceability across production phases. Leaders should prioritize the integration of advanced quality control measures and predictive analytics to minimize production variability while optimizing throughput.

An emphasis on strategic partnerships and collaborations is also paramount. By engaging with regulatory bodies, technology providers, and research institutions, companies can stay ahead of evolving compliance requirements and drive innovation collaboratively. Additionally, there is a critical need to diversify service portfolios to address the intricate demands of different end-user segments. This diversification includes tailoring offerings to specialized applications such as monoclonal antibody production, gene therapy advancements, and scaffold-based tissue engineering solutions.

Furthermore, continuous workforce training and development represent a vital component of maintaining industry leadership. Companies should foster environments that encourage knowledge sharing and cross-disciplinary expertise, thereby ensuring that teams remain agile and adept in implementing sophisticated GMP protocols. A proactive approach to market intelligence, combined with an investment in scalable infrastructure, will empower leaders to efficiently navigate the complexities of globalization and future-proof their operational strategies.

Conclusion: The Future of GMP Cell Banking Services

The evolution of GMP Cell Banking Services is marked by a synthesis of technological advancements, regulatory clarity, and strategic segmentation. The market's transformation from conventional approaches to a modern, technology-driven ecosystem has been accelerated by global trends and regional dynamics that cater to both mature and emerging biopharmaceutical requirements. This comprehensive examination of market trends, segmentation intricacies, and corporate dynamics has illuminated the path forward for stakeholders.

In summary, the ongoing innovation in cell banking is reshaping the landscape, enabling organizations to achieve greater efficiency, enhanced quality, and improved compliance with regulatory standards. Stakeholders are therefore better positioned to capitalize on emerging opportunities, ensuring that future manufacturing processes are not only robust and scalable, but also agile enough to adapt to the rapidly evolving scientific and regulatory environment.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases boosting the requirement for effective and efficient cell banks
    • 5.1.1.2. Increasing demand for personalized medicine enhances the need for GMP cell banking services
    • 5.1.1.3. Rising investment in biopharmaceuticals & pharmaceutical sectors across the globe
  • 5.1.2. Restraints
    • 5.1.2.1. Cost implications and investment obstacles affecting the GMP cell banking services
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements elevating the expectations for precision and reliability in GMP cell banking
    • 5.1.3.2. Development of regenerative medicine and immune therapies necessitating sophisticated cell banking repositories
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for GMP compliance and cell banking approvals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Cell Type: Expansion of personalized medicine and regenerative therapies boost the demand for human cells
  • 5.2.2. End-User: Increasing investments in the pharmaceutical & biopharmaceutical sector, enhancing their cell banking infrastructure,
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. GMP Cell Banking Services Market, by Cell Type

• 6.1. Introduction
• 6.2. Animal Cells
• 6.3. Human Cells

7. GMP Cell Banking Services Market, by Quality Grade

• 7.1. Introduction
• 7.2. Clinical Grade
• 7.3. Research Grade

8. GMP Cell Banking Services Market, by Service Type

• 8.1. Introduction
• 8.2. End-of-Production Cell Banking
• 8.3. Master Cell Banking
• 8.4. Working Cell Banking

9. GMP Cell Banking Services Market, by Application

• 9.1. Introduction
• 9.2. Biopharmaceutical Production
  • 9.2.1. Monoclonal Antibodies
  • 9.2.2. Recombinant Proteins
• 9.3. Research & Development
  • 9.3.1. Cell Therapy
  • 9.3.2. Gene Therapy
  • 9.3.3. Stem Cell Research
• 9.4. Tissue Engineering
  • 9.4.1. Bioprinting Technologies
  • 9.4.2. Organ Transplant Solutions
  • 9.4.3. Scaffold-Based Applications

10. GMP Cell Banking Services Market, by End-User

• 10.1. Introduction
• 10.2. Contract Research Organizations
• 10.3. Hospitals
• 10.4. Pharmaceutical Companies
• 10.5. Research Institutes

11. Americas GMP Cell Banking Services Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific GMP Cell Banking Services Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa GMP Cell Banking Services Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. I Peace's breakthrough in GMP iPSC manufacturing sets new standards in regenerative medicine and personalized cell banking
  • 14.3.2. Strategic collaboration between CellSave Arabia and Sidra Medicine to enhance stem cell banking in Qatar, advancing regenerative medicine and healthcare accessibility
  • 14.3.3. REPROCELL USA's new facility strengthens GMP cell banking capabilities with advanced closed system technology
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 53Biologics
• 2. Austrianova
• 3. Cell Culture Company, LLC
• 4. Charles River Laboratories
• 5. Clean Cells
• 6. Eurofins Scientific Limited
• 7. ExcellGene SA
• 8. Goodwin Biotechnology Inc.
• 9. Kaneka Eurogentec S.A.
• 10. Lonza Group Ltd.
• 11. Merck KGaA
• 12. NAOBIOS
• 13. PackGene Biotech lnc.
• 14. ProBio Biotech Corporation
• 15. RoslinCT
• 16. SGS Group
• 17. SK pharmteco Inc.
• 18. Takara Bio Inc.
• 19. Texcell SA
• 20. uBriGene Biosciences International Co.
• 21. ViruSure GmbH
• 22. Wacker Chemie AG
• 23. WuXi Biologics